PR Towards better quality of life, GNT Pharma

언론보도

"지엔티파마" 반려견 치매 임상 3 상 WORLD NEWS RELEASE

페이지 정보

profile_image

작성자 GNTPharma

조회 1,040회 작성일 2020-01-20 10:54

본문

USA


NewsWire

https://www.newswire.co.kr/newsRead.php?no=900031

BUSINESSWIRE

https://www.businesswire.com/news/home/20200114005324/en/GNT-Pharmas-Anti-dementia-Drug-crisdesalazine-Demonstrates-Efficacy

pharmaceutical DAILY

https://www.wallstreet-online.de/nachricht/12061676-gnt-pharmas-anti-demenz-medikament-crisdes

BIOPORTPOLIO

https://www.bioportfolio.com/news/article/4190666/GNT-Pharmas-Anti-dementia-Drug-crisdesalazine-Demonstrates-Efficacy-in-Phase-III-Clinical.html

WORLDNEWS(WN)

https://article.wn.com/view/2020/01/14/GNT_Pharmas_Antidementia_Drug_crisdesalazine_Demonstrates_Ef_9/

SreetInsider

https://www.streetinsider.com/Business+Wire/GNT+Pharmas+Anti-dementia+Drug+crisdesalazine+Demonstrates+Efficacy+in+Phase+III+Clinical+Study+with+Companion+Dogs+with+Dementia/16330765.html

ArchyW

https://www.archyworldys.com/gnt-anti-disease-drugs-pharma-of-efficacy-phase-iii-clinical-studies-with-dogs-empathy-with-dementia-t/

FINANCIAL POST

https://business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia

ASIA TODAY

http://asiatoday.com/pressrelease/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-phase-iii-clinical-

State of Affairs

https://stateofaffairs.news/press-release/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia/

THE360MEGAZINE

https://the360.blog/?page_id=176

Biospace

https://www.biospace.com/article/releases/gnt-pharma-s-anti-dementia-drug-crisdesalazine-demonstr

OTTAWA CITIZEN

https://ottawacitizen.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia/wcm/8509bd8f-290c-4f7e-bb95-348921643527

THE DAILY TIMES

https://www.thedailytimes.com/business/gnt-pharma-s-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in/article_3bfc6a8c-2812-54d8-9051-fbdc7479b1f5.html

OAOA

https://www.oaoa.com/news/business/article_5d4ec81f-cf8d-516e-afa8-bfa8b1f18596.html

WINDSOR STAR

https://windsorstar.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia/wcm/8509bd8f-290c-4f7e-bb95-348921643527

DIGITAL JOURNAL

http://www.digitaljournal.com/pr/4556385

THE ARGUS PRESS

https://www.argus-press.com/news/national/article_86439037-13ae-5e79-bc48-0064bf635f05.html

GLOBAL BANKING & FINANCE REVIEW

https://www.globalbankingandfinance.com/category/news/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia/

THE SUN CHRONICLE

https://www.thesunchronicle.com/test2/gnt-pharma-s-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in/article_aa44d253-6f4e-5d4d-9ee0-954f27ec0230.html

YAHOO NEWS

https://ca.news.yahoo.com/gnt-pharmas-anti-dementia-drug-110000510.html

NEWS ON FLOOR

https://newsonfloor.com/newsdetail/gnt-pharmas-antidementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia-44173.htm

ACROFAN

https://us.acrofan.com/detail.php?number=221683

MANCHESTER TIMES

https://www.manchestertimes.com/news/business/gnt-pharma-s-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in/article_fe458fbe-aeec-56d1-bcc0-06eb7cca4c23.html

BUSINESS BYTES

https://buzinessbytes.com/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia/#

  

China


HiNet

https://times.hinet.net/news/22740343

SINA

https://news.sina.com.tw/article/20200115/33994904.html

ETNET

http://www.etnet.com.hk/www/tc/news/interfax_news_detail.php?newsid=42526

yamNews

https://n.yam.com/Article/20200115283173

cna

https://www.cna.com.tw/Postwrite/Detail/267781.aspx#.XiAMMMgzaUk

china development advice

http://www.fzbdsd.com/caijing/202001/179040.html

HUAXIATOUXIAO

http://www.huaxiatouxiao.com/archives/view-10063-1.html

JIANGXIMINSHENG

http://www.jiangximinsheng.com/archives/view-11514-1.html

THE STAR CITY

http://www.thestarcity.com/v-1-651625.aspx

  

Japan


ZAIKEI

https://www.zaikei.co.jp/releases/933053/

JIJI

https://www.jiji.com/jc/article?k=20200114005328&g=bw

QLIFEPRO

http://www.qlifepro.com/press/20200115-08-54523/gnt-pharma-7/

Kingsoft

http://home.kingsoft.jp/news/pr/businesswire/20200114005328.html

ACROFAN

https://jp.acrofan.com/detail.php?number=82062

YAKUJI

https://www.yakuji.jp/entry103176.html

  

India


IANS

http://ians.in/index.php?param=prwiredetail/B-66571

TENNEWS

https://tennews.in/press-releases/66571/gnt-pharmas-anti-dementia-drug-crisdesalazine-demonstrates-efficacy-in-phase-iii-clinical-study-with-companion-dogs-with-dementia

  

France


Le Lezard

https://www.lelezard.com/communique-19091514.html

BOURSIKOTER

https://boursikoter.com/crisdesalazine-le-medicament-de-gnt-pharma-pour-prevenir-la-demence-demontre-son-efficacite-dans-une-etude-clinique-de-phase-iii-sur-des-chiens-de-compagnie-atteints-de-demence/

  

Germany


WALLSTREET ONLINE

https://www.wallstreet-online.de/nachricht/12061676-gnt-pharmas-anti-demenz-medikament-crisdes

FinanzNachrichten

https://www.finanznachrichten.de/nachrichten-2020-01/48604114-gnt-pharmas-anti-demenz-medikament-crisdesalazine-zeigt-wirksamkeit-in-klinischer-phase-iii-studie-bei-begleithunden-mit-demenz-004.htm

AD HOC NEWS

https://www.ad-hoc-news.de/boerse/news/unternehmensnachrichten/gnt-pharma-hat-eine-klinische-phase-iii-studie-fuer-crisdesalazine-ein/59695872

ONVISTA

https://www.onvista.de/news/gnt-pharmas-anti-demenz-medikament-crisdesalazine-zeigt-wirksamkeit-in-klinischer-

BOERSE

https://www.boerse.de/nachrichten/ROUNDUP-Aktien-Frankfurt-Schluss-Dax-Rekord-rueckt-in-greifbare-Naehe/12378049

AFP